For device companies, ASC operators, clinical research sponsors, conference organizers, and media.
I evaluate emerging technology carefully and I am passionate about being at the forefront of innovations that actually move the specialty forward. The future of urology belongs outside hospital walls.
Why ambulatory surgery centers are the future of urologic care delivery.
Clinical outcomes and the case for treating BPH outside the hospital.
Focal therapy for intermediate-risk prostate cancer, and where it fits.
Building a clinical career and a company alongside employed medicine.
Past and present relationships span device manufacturers, surgical distribution, ambulatory and interventional platforms, and digital men's health. Such as:
These relationships range from advisory and consulting engagements to founder and equity positions. Listing does not imply endorsement by the named company, and financial relationships are disclosed at the point of any clinical recommendation.
High-volume BPH and prostate practice with an on-site ambulatory surgery center and an established clinical research program.
Contributing investigator to international multi-center registries, including ICARUS, across multiple published analyses.
First author on the first-in-US study of Aquablation in the ambulatory surgery center setting.